glucosylated serum protein
serve as a sensitive, short-term integrator of blood glucose homeostasis in diabetes; see also glycosylated hemoglobins; see also record for glycosylated serum protein
Also Known As:
glucosylated blood proteins; serum protein, glucosylated
Networked: 3
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
| 1. | Jiao, Yukun:
1 article
(08/2017)
|
| 2. | Wang, Shumei:
1 article
(08/2017)
|
| 3. | Yan, Chunyan:
1 article
(08/2017)
|
| 4. | Zhang, Mengliu:
1 article
(08/2017)
|
| 5. | Cui, Taizhen:
1 article
(01/2017)
|
| 6. | Dong, Gaopan:
1 article
(01/2017)
|
| 7. | Feng, Yihang:
1 article
(01/2017)
|
| 8. | Li, Songji:
1 article
(01/2017)
|
| 9. | Wang, Xin:
1 article
(01/2017)
|
| 10. | Xu, Yahui:
1 article
(01/2017)
|
Related Diseases
| 1. | Insulin Resistance
01/01/2017
- " Despite significant metabolic risk profiles (as such lipid abnormalities and insulin resistance) increase, mean fasting glucose and glucosylated serum protein (GSP) were significantly decreased after the short term (median of 23days) antipsychotics exposure, compared to baseline. " 08/01/2017
- " In addition, GPs efficiently decreased levels of fasting blood glucose, glucosylated serum protein, serum insulin, homeostasis model assessment of insulin resistance, total cholesterol, triglyceride and serum alanine transaminase, improved oral glucose tolerance, and increased insulin sensitivity in rats with T2DM. "
|
| 2. | Hyperglycemia
|
|
Related Drugs and Biologics